Community Health Systems, Inc. (NYSE: CYH) announced that Kevin Hammons will become chief executive officer and Jason Johnson will become chief financial officer, effective immediately. The board’s decision follows interim appointments that began on October 1, 2025 and reflects confidence in a leadership team that has deep institutional knowledge and a proven track record of executing the company’s transformation agenda.
Kevin Hammons, who has been with CHS since 1997, served as chief financial officer from January 2020 through September 2025. During that tenure he led the “Project Empower” enterprise‑resource‑planning rollout, a combined Oracle Health ERP and legacy‑system integration that is expected to deliver up to $60 million in annual cost savings and improve data visibility across the 70‑hospital network.
Jason Johnson, a CHS employee since 2012, was chief accounting officer from December 2019 and has overseen the company’s financial reporting, treasury, and investor relations functions. His appointment as CFO brings continuity to the finance team and positions the company to accelerate its debt‑reduction and portfolio‑optimization initiatives.
The leadership change comes as CHS continues to tackle a high leverage profile—$10.6 billion of long‑term debt against $123 million in cash, a net‑debt‑to‑EBITDA ratio of 7.6×. In August 2025 the company refinanced $1.7 billion of senior secured notes and has sold non‑core assets, including laboratory services to Labcorp for $194 million, to shore up liquidity. The new executives are expected to drive further deleveraging, support the divestiture of legacy hospitals, and invest in technology that enhances operational efficiency.
CHS’s Q3 2025 results provide context for the leadership transition. Revenue rose 6% to $3.09 billion, beating the consensus estimate of $3.00 billion by $90 million, largely driven by a 6% increase in same‑store revenue in core hospital segments. Earnings per share of $1.27 surpassed the consensus of $0.30 by $0.97, a beat of 323%, reflecting disciplined cost control and the continued impact of the ERP rollout on operating efficiency. Operating income reached $243 million, a 7.9% margin, up from 7.4% in the prior quarter, as the company leveraged scale and improved mix. Management guided 2025 net income per share to $0.80–$0.90, a slight upward revision that signals confidence in sustaining profitability while completing debt‑reduction milestones.
In a statement, Hammons said, “I am honored to lead CHS at a time when we have strong operational momentum and a clear path to sustainable growth. Our focus will be on delivering value to patients, employees, and shareholders through disciplined execution and strategic investments.” Johnson added, “The transition to a permanent CFO role allows us to accelerate our financial discipline, continue the successful ERP implementation, and support the company’s long‑term capital‑structure goals.”
revised_sentiment_rating
importance
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.